Skip to content

Evaluation of a New Invitation Procedure to the French Organized Colorectal Cancer Screening Program

Evaluation of the Home Delivery of the Screening Kit, and Impact of a Prior Notification Among New Participants to the National Organized Colorectal Cancer Screening Program (Among New Participants Only)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05589675
Acronym
KITCOLO22
Enrollment
71117
Registered
2022-10-21
Start date
2023-04-01
Completion date
2025-10-27
Last updated
2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

colorectal cancer, screening program, pilot project, randomised control trial, France

Brief summary

This is a randomized controlled trial comparing the effect on participation rates to colorectal cancer screening between an intervention arm (invitation letter to the screening program including a FIT test with or without prior notification) and a control arm with the standard of care (invitation letter to visit the GP who will deliver the FIT test).

Detailed description

The participation to the national screening program for colorectal cancer in France is low. In order to improve the performances of its organized program, the National Cancer Institute is planning to modify the invitation procedure. This is a pilot project and if an improvement in the program performances is reported, the invitation procedure may be scaled up. Eligible individuals for colorectal cancer screening will be identified by the Regional Cancer Screening Coordinating Centre and randomized into the intervention or control arms. They will be followed for FIT test submission to the central laboratory (participation to screening). Those who did not send their test will receive reminder letters. Those who had a positive FIT test will be followed up for coloscopy referral, and result of the coloscopy. Comparison of the participation rates to screening program and to coloscopy among those with a positive FIT test will be compared between the two study arms.

Interventions

OTHERDispatch of the screening test along the invitation letter to the national colorectal cancer screening program

The individuals eligible for the colorectal cancer screening program will receive at home an invitation letter to participate to the program along with a FIT test. The follow-up will be similar to the standard of care, i.e. reminder letters at 5 and 10 months if there is no participation, and reminders if no coloscopy after a positive FIT test

OTHERSending of a prior notification to the new entrants of the national program

Dispatch of a notification, one month prior the dispatch of the screening test along the invitation letter. This intervention is among the new entrants to the national program

Sponsors

International Agency for Research on Cancer
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

This is a three-arm study with a parallel study design

Eligibility

Sex/Gender
ALL
Age
50 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

* Women and men aged 50 to 74 years old * Living in the study area (Departments of Ardennes, Meurthe-et-Moselle, and Moselle, France) * At moderate risk of colorectal cancer, i.e. eligible to the organised programme and receiving the first invitation of the screening round (not a reminder letter)

Exclusion criteria

* Outside the target age (less than 50 years old, or 75 years and more) * Receiving the reminder letter * At high or very high risk of colorectal cancer

Design outcomes

Primary

MeasureTime frameDescription
Participation rates to the screening program2 yearsComparison of the participation rate to the screening program between the intervention and the control arms

Secondary

MeasureTime frameDescription
Participation rates to the screening program2 yearsComparison of the participation rates to the screening program between the individuals aged 50-52 of the Intervention1 and the Intervention sub-study arms
Referral rates to coloscopy among those FIT positive2 yearsComparison of the referral rates to coloscopy between the intervention and the control arms

Countries

France

Contacts

PRINCIPAL_INVESTIGATORMaurice TANGUY, MD

Regional Cancer Screening Coordinating Centre, Meurthe-et-Moselle site, Nancy, France

PRINCIPAL_INVESTIGATORMyriam GUERBAZ SOMMI, MD

Regional Cancer Screening Coordinating Centre, Moselle site, Metz, France

PRINCIPAL_INVESTIGATORJean BOTO KEKY, MD

Regional Cancer Screening Coordinating Centre, Ardennes site, Charleville-Mézières, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026